MariMed Inc. (MRMD) Reports Q1 Loss, Beats Revenue Estimates
MariMed Inc. (MRMD) delivered earnings and revenue surprises of 0.00% and +3.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
More News
Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates
Sanuwave Health (SNWV) delivered earnings and revenue surprises of -21.43% and +0.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of +29.17% and +4.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Myomo, Inc. (MYO) Reports Q1 Loss, Beats Revenue Estimates
Myomo (MYO) delivered earnings and revenue surprises of +21.74% and +8.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
MariMed Inc. (MRMD) Reports Q3 Loss, Misses Revenue Estimates
MariMed Inc. (MRMD) delivered earnings and revenue surprises of 0.00% and -3.29%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
MariMed Inc. (MRMD) Upgraded to Strong Buy: What Does It Mean for the Stock?
MariMed Inc. (MRMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Fast-paced Momentum Stock MariMed Inc. (MRMD) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, MariMed Inc. (MRMD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Why Fast-paced Mover MariMed Inc. (MRMD) Is a Great Choice for Value Investors
MariMed Inc. (MRMD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
Despite industry headwinds, Envista, BioLife Solutions, InfuSystems and MariMed are leveraging innovation and strategy for growth.
Despite Fast-paced Momentum, MariMed Inc. (MRMD) Is Still a Bargain Stock
MariMed Inc. (MRMD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.